Skip to main content
TipRanks
Go Ultimate75% OFF

Summit Therapeutics (SMMT) Drug Pipeline

1 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Pembrolizumab, Enfortumab Vedotin, Ivonescimab Dose 1, Ivonescimab Dose 2, Ivonescimab Rp3dMetastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma (Uc)phase2AndPhase3RecruitingA Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial CarcinomaAug 31, 2026
Carboplatin, Ak138d1, IvonescimabNon-small Cell Lung Cancerphase1AndPhase2RecruitingA Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung CancerMay 28, 2026
Cetuximab, Daraxonrasib, Ivonescimab, Elironrasib, Zoldonrasib, Carboplatin/Cisplatin + PemetrexedAdvanced Solid Tumors, Non-Small Cell Lung Cancer (Nsclc), Nsclc, Metastatic Solid Tumors, Colorectal Cancer (Crc), Crcphase1AndPhase2RecruitingStudy of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid TumorsFeb 02, 2026
Drug: Ivonescimab Injection, Drug: Bevacizumab InjectionMetastatic Colorectal Cancer (Crc)Phase IIIRecruitingPhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal CancerNov 10, 2025
Ivonescimab Injection, Pembrolizumab InjectionNon-small Cell Lung CancerPhase IIIRecruitingClinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1Jan 03, 2025
Ivonescimab Injection, Pembrolizumab InjectionNon-small Cell Lung CancerPhase IIIActive Not RecruitingClinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC PatientsJun 01, 2023
Oxaliplatin, Irinotecan, Capecitabine, Leucovorin, 5-Fluorouracil, Ak112, Ak117Metastatic Colorectal CancerPhase IIActive Not RecruitingA Study of AK112 With or Without AK117 in Metastatic Colorectal CancerMay 16, 2022―
Vancomycin, RidinilazoleClostridioides Difficile InfectionPhase IIICompletedComparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile InfectionJun 11, 2018―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Summit Therapeutics PLC (MX:SMMT) have in its pipeline
Summit Therapeutics MX:SMMT is currently developing the following drugs: Pembrolizumab, Enfortumab Vedotin, Ivonescimab Dose 1, Ivonescimab Dose 2, Ivonescimab Rp3d, Carboplatin, Ak138d1, Ivonescimab, Cetuximab, Daraxonrasib, Ivonescimab, Elironrasib, Zoldonrasib, Carboplatin/Cisplatin + Pemetrexed, Drug: Ivonescimab Injection, Drug: Bevacizumab Injection, Ivonescimab Injection, Pembrolizumab Injection, Oxaliplatin, Irinotecan, Capecitabine, Leucovorin, 5-Fluorouracil, Ak112, Ak117, Vancomycin, Ridinilazole. These drug candidates are in various stages of clinical development as the company works toward FDA approval.